Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis
Open accessThe DOI matches its Crossref record; 319 of the 333 references it cites were found in a registry or an index.
Abstract
Human T lymphotropic viruses (HTLVs) are complex deltaretroviruses that do not contain a proto-oncogene in their genome, yet are capable of transforming primary T lymphocytes both in vitro and in vivo. There are four known strains of HTLV including HTLV type 1 (HTLV-1), HTLV-2, HTLV-3 and HTLV-4. HTLV-1 is primarily associated with adult T cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). HTLV-2 is rarely pathogenic and is sporadically associated with neurological disorders. There have been no diseases associated with HTLV-3 or HTLV-4 to date. Due to the difference in the disease manifestation between HTLV-1 and HTLV-2, a clear understanding of their individual pathobiologies and the role of various viral proteins in transformation should provide insights into better prognosis and prevention strategies. In this review, we aim to summarize the data accumulated so far in the transformation and pathogenesis of HTLV-1, focusing on the viral Tax and HBZ and citing appropriate comparisons to HTLV-2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Tomita, M., Semenza, G. L., Michiels, C., Matsuda, T., Uchihara, J.-N., Okudaira, T., Tanaka, Y., Taira, N., Ohshiro, K., & Mori, N. (2007) · Biochemical Journal · doi:10.1042/bj20070286 · Cited by 46 · cited 2×
“Mechanistically, Tax frees a catalytic p110 subunit of the PI3K complex from an inhibitory p85 subunit by binding directly to the latter [256]; Tax induces the RelA-mediated sequestration of p300 from the promoters of phosphatase and tensin homolog (PTEN) and SH2 domain-containing inositol phosphatase - 1 (SHIP-1),…”
BackgroundRetractedHuman T-Cell Leukemia Virus Type 1 Tax Dysregulates β-CateninSignaling
Tomita, M., Kikuchi, A., Akiyama, T., Tanaka, Y., & Mori, N. (2006) · Journal of Virology · doi:10.1128/jvi.00739-06 · Cited by 36
RetractedFukuda, R.-I., Tsuchiya, K., Suzuki, K. A. O., Itoh, K., Fujita, J., Utsunomiya, A., & Tsuji, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806325200 · Cited by 21
RetractedPoiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., & Gallo, R. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7415 · Cited by 5,043 · cited 2×
“HTLV-1 was originally identified in 1980 in a T cell line derived from a patient with cutaneous T cell lymphoma [1] and was also detected in adult T cell leukemia (ATL) patients [2,3].”
BackgroundPhosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766 · cited 1×
“enhancer [204,205,207].”
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Regulation and Function of NF-κB Transcription Factors in the Immune System
Vallabhapurapu, S., & Karin, M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132641 · Cited by 2,588 · cited 2×
“(p50/p105) and NF-B2 (p52/p100) [204-206].”
BackgroundHTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY
Osame, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Igata, A., Matsumoto, M., & Tara, M. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91298-5 · Cited by 2,404 · cited 1×
“On the contrary, for HAM/TSP, disease progression can typically occur within a few years of infection [94,98].”
BackgroundIntegrating cell-signalling pathways with NF-κB and IKK function
Perkins, N. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2083 · Cited by 2,350
Hinuma, Y., Nagata, K., Hanaoka, M., Nakai, M., Matsumoto, T., Kinoshita, K. I., Shirakawa, S., & Miyoshi, I. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6476 · Cited by 2,252
Research works printed but not linked: 2
- Matsumoto, 1979, Adult T-cell leukemia-lymphoma in Kagoshima District, southwestern Japan: Clinical and hematological characteristics, Jpn. J. Clin. Oncol., 9, 325
- Murata, 1996, Prevention of HTLV-1 infection in Japanese macaques by passive immunization, Leukemia, 10, 1971
Cited by
Hijacking of the AP-1 Signaling Pathway during Development of ATL
Gazon, H., Barbeau, B., Mesnard, J.-M., & Peloponese, J.-M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02686 · Cited by 250
“A subset of HTLV-1-infected individuals will develop ATL after an extended period of time (Matsuoka and Jeang, 2007; Kannian and Green, 2011).”
BackgroundViral Oncology: Molecular Biology and Pathogenesis
Mui, U., Haley, C., & Tyring, S. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6120111 · Cited by 222
Morales-Sánchez, A., & Fuentes-Pananá, E. (2014) · Viruses · doi:10.3390/v6104047 · Cited by 220
“(reviewed in [89]).”
The Role of Cytidine Deaminases on Innate Immune Responses against Human Viral Infections
Vieira, V. C., & Soares, M. A. (2013) · BioMed Research International · doi:10.1155/2013/683095 · Cited by 118
Mechanisms of Oncogenesis by HTLV-1 Tax
Mohanty, S., & Harhaj, E. W. (2020) · Pathogens · doi:10.3390/pathogens9070543 · Cited by 131
Koala retroviruses: characterization and impact on the life of koalas
Denner, J., & Young, P. R. (2013) · Retrovirology · doi:10.1186/1742-4690-10-108 · Cited by 100
“In some cases retroviruses are nonpathogenic, for example the foamy viruses [32,33], while others, such as MuLV [2,3], FeLV [4,5], GaLV [6], and HTLV [7] induce leukemia in the corresponding host.”
InfluentialExtrahepatic cancers and chronic HCV infection
Pol, S., Vallet‐Pichard, A., & Hermine, O. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.172 · Cited by 96
NF ‐κB signaling mechanisms in HTLV ‐1‐induced adult T‐cell leukemia/lymphoma
Harhaj, E. W., & Giam, C. (2018) · FEBS Journal · doi:10.1111/febs.14492 · Cited by 95
Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers
Tornesello, M. L., Annunziata, C., Tornesello, A. L., Buonaguro, L., & Buonaguro, F. M. (2018) · Cancers · doi:10.3390/cancers10070213 · Cited by 99
“The HTLV-1 is recognized as the etiologic agent of adult T-cell leukemia (ALT) and of degenerative, neurological disorders such as tropical spastic paraparesis and HTLV-1-associated myelopathy [41,42].”
BackgroundTrivedi, M., Talekar, M., Shah, P., Ouyang, Q., & Amiji, M. M. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.52 · Cited by 84
Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses
Simonis, N., Rual, J.-F. M., Lemmens, I. H., Boxus, M., Hirozane-Kishikawa, T., Gatot, J., Dricot, A., Hao, T., Vertommen, D., Legros, S., et al. (2012) · Retrovirology · doi:10.1186/1742-4690-9-26 · Cited by 80
“The elaborate pathogenicity of HTLV-1 involves establishment and reactivation of latent stages, transcriptional activation of specific cellular genes, and modulation of cell death and proliferation pathways [6].”
BackgroundHIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread
Kalinichenko, S., Komkov, D., & Mazurov, D. (2022) · Viruses · doi:10.3390/v14010152 · Cited by 68
“5 kb) contain the main retroviral genes gag, pro, pol, and env, and are flanked by long terminal repeats (LTRs) of about 600 nt [8,9].”
BackgroundThe Role of miRNAs in Virus-Mediated Oncogenesis
Vojtěchová, Z., & Tachezy, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041217 · Cited by 69
“The second important oncogenic protein is HTLV-1 bZIP factor (HBZ), which is present in 100% of ATL cells, enhances T-cell proliferation, and contributes to the prevention of apoptosis [175].”
BackgroundImmunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP)
Fuzii, H. T., Dias, G. A. D. S., de Barros, R. J. S., Falcão, L. F. M., & Quaresma, J. A. S. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.03.025 · Cited by 65
Highlights on distinctive structural and functional properties of HTLV Tax proteins
Romanelli, M. G., Diani, E., Bergamo, E., Casoli, C., Ciminale, V., Bex, F., & Bertazzoni, U. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00271 · Cited by 68
Corrigan-Curay, J., Cohen-Haguenauer, O., O'Reilly, M., Ross, S. R., Fan, H., Rosenberg, N., Somia, N., King, N., Friedmann, T., Dunbar, C., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.93 · Cited by 50
Marseillevirus in lymphoma: a giant in the lymph node
Aherfi, S., Colson, P., Audoly, G., Nappez, C., Xerri, L., Valensi, A., Million, M., Lépidi, H., Costello, R. T., & Raoult, D. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30051-2 · Cited by 51
HTLV-1 Rex: the courier of viral messages making use of the host vehicle
Nakano, K., & Watanabe, T. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00330 · Cited by 59
“Information concerning the function of HTLV-1 accessory proteins including Rex in the regulation of viral replication has been accumulated and updated during the last decade (Johnson et al., 2001; Franchini et al., 2003; Kashanchi and Brady, 2005; Taylor and Nicot, 2008; Kannian and Green, 2010).”
BackgroundOncogenic viruses and chemoresistance: What do we know?
Nahand, J. S., Rabiei, N., Fathazam, R., Taghizadieh, M., Ebrahimi, M. S., Mahjoubin‐Tehran, M., Baghi, H. B., Khatami, A., Abbasi‐Kolli, M., Mirzaei, H. R., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105730 · Cited by 50
Animal models on HTLV-1 and related viruses: what did we learn?
Hajj, H. E., Nasr, R., Kfoury, Y., Dassouki, Z., Nasser, R., Kchour, G., Hermine, O., Thé, H. D., & Bazarbachi, A. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00333 · Cited by 42
“Both Tax and HBZ were shown to be linked to HTLV-1 pathogenesis (Boxus and Willems, 2009; Kannian and Green, 2010).”
BackgroundThe HTLV-1-encoded protein HBZ directly inhibits the acetyl transferase activity of p300/CBP
Wurm, T., Wright, D. G., Polakowski, N. J., Mesnard, J.-M., & Lemasson, I. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks244 · Cited by 46
“HTLV-1 encodes several unique proteins that participate in viral replication, viral infectivity, persistence and transformation (32).”
BackgroundPD-1 and PD-L1 inhibitors foster the progression of adult T-cell Leukemia/Lymphoma
Jalili‐Nik, M., Soltani, A., Mashkani, B., Rafatpanah, H., & Hashemy, S. I. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107870 · Cited by 43
Chevalier, S. A., Durand, S., Dasgupta, A., Radonovich, M., Cimarelli, A., Brady, J. N., Mahieux, R., & Pise-Masison, C. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041003 · Cited by 40
“Tax-1 and Tax-2 have also been shown to play a pivotal role in the immortalization and transformation of infected cells by altering cellular gene expression and protein function [20,26,34,36,65].”
BackgroundJourno, C., Bonnet, A., Favre-Bonvin, A., Turpin, J., Vinera, J., Côté, E., Chevalier, S. A., Kfoury, Y., Bazarbachi, A., Pique, C., et al. (2013) · Journal of Virology · doi:10.1128/jvi.01792-12 · Cited by 40
Yin, H., Kannian, P., Dissinger, N. J., Haines, R., Niewiesk, S., & Green, P. L. (2012) · Journal of Virology · doi:10.1128/jvi.00717-12 · Cited by 46
Self-citationB′-protein phosphatase 2A is a functional binding partner of delta-retroviral integrase
Maertens, G. N. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1347 · Cited by 38
“Although Tax is only expressed in ∼40% of the ATL cases, it is thought to contribute to the early stages of cellular transformation (44).”
Nasr, R., Hajj, H. E., Kfoury, Y., Thé, H. D., Hermine, O., & Bazarbachi, A. (2011) · Viruses · doi:10.3390/v3060750 · Cited by 35
“Both Tax and HBZ expression is linked to different stages of HTLV-I pathogenesis [16,17].”
BackgroundPrevalence and phylogenetic analysis of HTLV‐1 in a segregated population in Iran
Rafatpanah, H., Torkamani, M., Valizadeh, N., Vakili, R., Mashkani, B., Khademi, H., Gerayli, S., Mozhgani, S., & Rezaee, S. A. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24448 · Cited by 33
Tarokhian, H., Rahimi, H., Mosavat, A., Shirdel, A., Rafatpanah, H., Akbarin, M. M., Bari, A., Ramezani, S., & Rezaee, S. A. (2018) · BMC Cancer · doi:10.1186/s12885-018-5209-5 · Cited by 33
Cachat, A., Chevalier, S. A., Alais, S., Ko, N. L., Ratner, L., Journo, C., Dutartre, H., & Mahieux, R. (2013) · Journal of Virology · doi:10.1128/jvi.02758-13 · Cited by 33
Boostani, R., Vakili, R., Hosseiny, S. S., Shoeibi, A., Fazeli, B., Etemadi, M. M., Sabet, F., Valizade, N., & Rezaee, S. A. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0369-3 · Cited by 34
“Human T-cell leukemia virus type I (HTLV-1) is a retrovirus that has been extensively studied for>30 years [1].”
BackgroundHTLV-1 Rex Tunes the Cellular Environment Favorable for Viral Replication
Nakano, K., & Watanabe, T. (2016) · Viruses · doi:10.3390/v8030058 · Cited by 40
“The structure of the genomic HTLV-1 RNA and the molecular events triggered by HTLV-1 infection have been thoroughly investigated [3–7].”
BackgroundMalignancy and viral infections in Sub-Saharan Africa: A review
Diakité, M., Shaw‐Saliba, K., & Lau, C. (2023) · Frontiers in Virology · doi:10.3389/fviro.2023.1103737 · Cited by 39
Peridinin, a carotenoid, inhibits proliferation and survival of HTLV-1-infected T-cell lines
Ishikawa, C., Jomori, T., Tanaka, J., Senba, M., & Mori, N. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3648 · Cited by 30
TRAF3 Is Required for NF-κB Pathway Activation Mediated by HTLV Tax Proteins
Fochi, S., Bergamo, E., Serena, M., Mutascio, S., Journo, C., Mahieux, R., Ciminale, V., Bertazzoni, U., Zipeto, D., & Romanelli, M. G. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01302 · Cited by 31
Lack of antiviral antibody response in koalas infected with koala retroviruses (KoRV)
Fiebig, U., Keller, M., Möller, A., Timms, P., & Denner, J. (2015) · Virus Research · doi:10.1016/j.virusres.2015.01.002 · Cited by 30
Cell Surface Markers in HTLV-1 Pathogenesis
Thoma‐Kress, A. K., Grassmann, R., & Fleckenstein, B. (2011) · Viruses · doi:10.3390/v3081439 · Cited by 35
“To promote cell proliferation, Tax can stimulate the expression of cellular proteins controlling proliferation and survival [21–23].”
BackgroundEpitope-based universal vaccine for Human T-lymphotropic virus-1 (HTLV-1)
Raza, M. T., Mizan, S., Yasmin, F., Akash, A., & Shahik, S. M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248001 · Cited by 33
Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities
Chowdhary, S., Deka, R., Panda, K., Kumar, R., Solomon, A. D., Das, J., Kanoujiya, S. N., Gupta, A. K., Sinha, S., Ruokolainen, J., et al. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c01080 · Cited by 33
Ramezani, S., Shirdel, A., Rafatpanah, H., Akbarin, M. M., Tarokhian, H., Rahimi, H., Bari, A., Jahantigh, H. R., & Rezaee, S. A. (2017) · Medical Microbiology and Immunology · doi:10.1007/s00430-017-0506-1 · Cited by 27
HTLV-1 Tax protein recruitment into IKKε and TBK1 kinase complexes enhances IFN-I expression
Diani, E., Avesani, F., Bergamo, E., Cremonese, G., Bertazzoni, U., & Romanelli, M. G. (2014) · Virology · doi:10.1016/j.virol.2014.12.005 · Cited by 29
“Tax-1 is involved in the induction of oncogenic signaling activation and T-cells transformation in vitro (Azran et al., 2004; Matsuoka and Jeang, 2007; Kannian and Green, 2010; Ohsugi, 2013).”
BackgroundBarrios, C. S., Abuerreish, M., Lairmore, M. D., Castillo, L., Giam, C., & Beilke, M. A. (2011) · Viral Immunology · doi:10.1089/vim.2011.0037 · Cited by 28
Harakeh, S., Diab‐Assaf, M., Azar, R., Hassan, H. M. A., Tayeb, S. O., Abou‐El‐Ardat, K., Damanhouri, G. A., Qadri, I., Abuzenadah, A. M., Chaudhary, A., et al. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.3.1219 · Cited by 25
Molecular biology of human T cell leukemia virus
Ratner, L. (2019) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2019.04.003 · Cited by 25
Portrait of the Intrinsically Disordered Side of the HTLV-1 Proteome
Lyngdoh, D. L., Shukla, H., Sonkar, A. K., Anupam, R., & Tripathi, T. (2019) · ACS Omega · doi:10.1021/acsomega.9b01017 · Cited by 20
“24,55 The HTLV-1 nonstructural proteins are encoded within four ORFs present within the pX region.”
InfluentialPathways involved in viral oncogenesis: New perspectives from virus-host protein interactomics
Kori, M., & Arğa, K. Y. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165885 · Cited by 23
Mechanisms of Innate Immune Sensing of HTLV-1 and Viral Immune Evasion
Mohanty, S., & Harhaj, E. W. (2023) · Pathogens · doi:10.3390/pathogens12050735 · Cited by 20
“The viral genome is flanked at 5 (cid:48) and 3 (cid:48) ends with long terminal repeats (LTRs) crucial for viral transcription, integration, and translation [14].”
Rusin, A., Seymour, C. B., Cocchetto, A. M., & Mothersill, C. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020691 · Cited by 22
Romeo, M., Ko, B., Kim, J., Brady, R., Heatley, H. C., He, J., Harrod, C. K., Barnett, B., Ratner, L., Lairmore, M. D., et al. (2015) · Virology · doi:10.1016/j.virol.2014.12.008 · Cited by 24
“The HTLV-1 encodes three latency-maintenance factors: p30II, HBZ, and p13II (Johnson et al., 2001; Kannian and Green, 2010; Lairmore et al., 2012; Nicot et al., 2005; Edwards et al., 2011; Silic-Benussi et al., 2010; Bai and Nicot, 2012; Arnold et al., 2006; Awasthi et al., 2005; Li et al., 2009;…”
BackgroundOncoviruses: How do they hijack their host and current treatment regimes
Ahmed, K., & Jha, S. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188960 · Cited by 24
Natural Products Mediated Targeting of Virally Infected Cancer
Fatima, I., Kanwal, S., & Mahmood, T. (2019) · Dose-Response · doi:10.1177/1559325818813227 · Cited by 16
The Role of Bcl-xL Protein in Viral Infections
Wyżewski, Z., Świtlik, W. Z., Mielcarska, M. B., & Gregorczyk-Zboroch, K. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041956 · Cited by 18
“, capsid protein, protease, polymerase, and envelope protein), and also comprises four overlapping open reading frames encoding regulatory factors [106,107].”
BackgroundRole of Exosomes in Human Retroviral Mediated Disorders
Anderson, M. R., Kashanchi, F., & Jacobson, S. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9784-7 · Cited by 18
Mcl-1 Protein and Viral Infections: A Narrative Review
Wyżewski, Z., Stępkowska, J., Kobylińska, A. M., Mielcarska, A., & Mielcarska, M. B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021138 · Cited by 14
“Two identical strands of single-stranded positive-sense RNA are located in an enveloped virion approximately 100 nm in diameter [59].”
BackgroundGenetic diversity of STLV-2 and interspecies transmission of STLV-3 in wild-living bonobos
Ahuka‐Mundeke, S., Lunguya-Metila, O., Mbenzo-Abokome, V., Butel, C., Inogwabini, B., Omasombo, V., Muyembé‐Tamfum, J., Georgiev, A. V., Muller, M. N., Ndjango, J.-B. N., et al. (2016) · Virus Evolution · doi:10.1093/ve/vew011 · Cited by 14
“Only about 5% of HTLV-1 infections are associated with disease, including adult T-cell leukaemia/ lymphoma and tropical spastic paraparesis (Gessain et al. 1995; Kannian and Green 2010; Gessain and Mahieux 2012).”
BackgroundHuman Oncogenic Viruses and Cancer
Ahuja, R., Jamal, A., Nosrati, N., Pandey, V., Rajput, P., Saxena, N., Sidhu, K., & Kumar, V. (2014) · doi:10.18520/cs/v107/i5/768-785 · Cited by 12
Leucemia/linfoma T del adulto en pacientes infectados con HTLV-1: reporte de dos casos de Colombia
Medina, E. A. M., Orduz-Rodriguez, R., Morales-Reyes, O. L., Martínez, O., Baldión, M., & Isaza, M. (2013) · Biomédica · doi:10.7705/biomedica.v33i4.1429 · Cited by 13
Jafarian, M., Mozhgani, S., Patrad, E., Vaziri, H., Rezaee, S. A., Akbarin, M. M., & Norouzi, M. (2017) · Archives of Virology · doi:10.1007/s00705-016-3213-0 · Cited by 10
“izes human primary T-cells; approximately 60% of all ATLL cases do not express this protein [6, 7].”
BackgroundActivation of PKC-δ in HTLV-1-infected T cells
Mori, N., Ishikawa, C., & Senba, M. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2848 · Cited by 11
Tuning Rex rules HTLV-1 pathogenesis
Nakano, K., & Watanabe, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.959962 · Cited by 12
del Cauca, U., Caldon, C. C. R., López-Valencia, D., del Cauca, U., Zamora-Bastidas, T., del Cauca, U., Dueñas-Cuéllar, R., del Cauca, U., Mora-Obando, D., & del Cauca, U. (2017) · IATREIA · doi:10.14419/ijet.v8i1.9.26357 · Cited by 21
Altered Expression of Cell Cycle Regulators in Adult T-Cell Leukemia/ Lymphoma Patients.
Torshizi, R., Karimiani, E. G., Etminani, K., Akbarin, M. M., Jamialahmadi, K., Shirdel, A., Rahimi, H., Allahyari, A., Golabpour, A., & Rafatpanah, H. (2017) · PubMed · Cited by 12
Nakano, K., 唐澤伸明, Hashizume, M., Tanaka, Y., Ohsugi, T., Uchimaru, K., & Watanabe, T. (2022) · Viruses · doi:10.3390/v14020344 · Cited by 10
Identification and Characterization of HTLV-1 HBZ Post-Translational Modifications
Dissinger, N. J., Shkriabai, N., Hess, S. Y., Al-Saleem, J., Kvaratskhelia, M., & Green, P. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112762 · Cited by 13
Self-citationYaghoubi, N., Youssefi, M., Hashemy, S. I., Rafatpanah, H., Mashkani, B., & Avval, F. Z. (2018) · Journal of Medical Virology · doi:10.1002/jmv.25371 · Cited by 9
“lymphocyte activation, immune responses, lymphocyte survival, and lymphoid tissue development.(3,4) The other protein, Rex, is a positive regulator of posttranscriptional processes,(5) while p30 suppresses viral replication by binding to Tax and Rex mRNA in the nuclei.”
BackgroundHTLV-1 basic leucine zipper factor downregulates cyclin D1 expression via interactions with NF-κB
Ma, Y., Zhang, B., Wang, D., Qian, L., Song, X., Wang, X., Yang, C., & Zhao, G. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.2868 · Cited by 9
Jafarian, M., Mozhgani, S., Patrad, E., Vaziri, H., Rezaee, S. A., Akbarin, M. M., & Norouzi, M. (2017) · Archives of Virology · doi:10.1007/s00705-017-3272-x · Cited by 8
Mahdifar, M., Akbari-Eidgahi, M. R., Mosavat, A., Pourreza, A., Akbarin, M. M., Valizadeh, N., Sarbaz, M., Kiani, B., Rezaee, S. A., & Rafatpanah, H. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0001484 · Cited by 8
Mouse Models That Enhanced Our Understanding of Adult T Cell Leukemia
Moodad, S., Akkouche, A., Hleihel, R., Darwiche, N., El-Sabban, M. E., Bazarbachi, A. A., & Hajj, H. E. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00558 · Cited by 8
“Both Tax and HBZ are linked to HTLV-I pathogenesis (reviewed in Boxus and Willems, 2009; Kannian and Green, 2010; Giam and Semmes, 2016).”
BackgroundHTLV‑1‑associated genes as potential biomarkers for endometrial cancer
Du, G., Zhang, W., Zhang, Z., Zeng, M., & Wang, Y. (2019) · Oncology Letters · doi:10.3892/ol.2019.10389 · Cited by 11
“HTLV-1 infection symptoms may occur early in an individual's lifetime and generally have a long-term latent time period prior to tumorigenesis (14).”
BackgroundBiochemical strategies of E3 ubiquitin ligases target viruses in critical diseases
Dubey, A. R., Jagtap, Y. A., Kumar, P., Patwa, S. M., Kinger, S., Kumar, A., Singh, S., Prasad, A., Jana, N. R., & Mishra, A. (2021) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30143 · Cited by 8
“It is an enveloped retrovirus of around 100 nm in size, having 9 kb RNA genome coding for two oncogenes namely, Tax and HBZ.(99) The Tax protein can activate NF‐κB by associating with UbcH2/UhcH5c/UbcH7, acting as an E3 ligase.”
BackgroundInfluentialSohraby, F., & Aryapour, H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257916 · Cited by 8
Constitutive expression of IRF-5 in HTLV-1-infected T cells
Ishikawa, C., Senba, M., Barnes, B. J., & Mori, N. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3020 · Cited by 9
Tax is Involved in Up-regulation of HMGB1 Expression Levels by Interaction with C/EBP
Zhang, C., Wang, H., Niu, Z.-G., Zhang, J., Yin, M.-M., Gao, Z., & Hu, L. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.1.359 · Cited by 9
Dayyani, M., Hedayati‐Moghaddam, M. R., & Ar, A. (2015) · Iranian Journal of Blood and Cancer · Cited by 7
An Overview of the Unfolded Protein Response (UPR) and Autophagy Pathways in Human Viral Oncogenesis
Dutta, S., Ganguly, A., & Roy, S. G. (2024) · International review of cytology · doi:10.1016/bs.ircmb.2024.01.004 · Cited by 7
Viral Oncogenesis: Synergistic Role of Genome Integration and Persistence
Frazia, S. L., Pauciullo, S., Zulian, V., & Garbuglia, A. R. (2024) · Viruses · doi:10.3390/v16121965 · Cited by 15
“The proviral DNA of HTLV-1 obtained by reverse transcription, as in HIV, has two long terminal repeat (LTR) sequences at its ends [161,162].”
Map of thrombogenesis in viral infections and viral-driven tumours
Neto, B. V., Tavares, V., Santos, J., Cerqueira, F., Pereira, D., & Medeiros, R. (2023) · Discover Oncology · doi:10.1007/s12672-022-00610-1 · Cited by 6
“Indeed, approximately 3 to 5% of infected HTLV-1 patients develop ATL after a long latency period, often immunocompromised with a concurrent HIV infection [147, 150].”
BackgroundLeys, Y. E., Cameron, J., Frater, V., Thomas, K., Butterfield, T. R., Mitchell, M. C., Maddan, C., Moore, J., Pierre, R., Cloherty, G., et al. (2023) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.23-0118 · Cited by 9
Kannian, P., Fernández, S., Jones, K. S., & Green, P. L. (2013) · Journal of Virology · doi:10.1128/jvi.01079-13 · Cited by 7
Self-citationSohraby, F., & Aryapour, H. (2021) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2021.107616 · Cited by 7
Pedersen, F. S., Pyrz, M., & Duch, M. (2011) · Wiley eBooks · doi:10.1002/9780470015902.a0000430.pub3 · Cited by 8
Design of new potent HTLV-1 protease inhibitors: in silico study.
Kheirabadi, M., Maleki, J., Soufian, S., & Hosseini, S. (2016) · PubMed · Cited by 5
Noori, B., Shahbahrami, R., Douzandegan, Y., Mozhgani, S., Norouzi, M., & Jazayeri, S. M. (2026) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/cjid/8667755 · Cited by 6
“Human T-lymphotropic virus Type 1 (HTLV-1) is a human retrovirus frst isolated in 1980 [1, 2].”
Human T-cell leukemia virus type 1: oncogenic potential and vaccine development strategies
Vásconez-González, J., Suárez-Sangucho, I. A., Acosta-Muñoz, E., y Miño, L. P., Borja-Mendoza, D. A., Alexander-Castillo, J. A., Saa, J., Salazar-Calvopiña, N., Cárdenas, P., López‐Cortés, A., et al. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1587802 · Cited by 4
Yaghoubi, N., Youssefi, M., Panah, H. R., Jarahi, L., & Avval, F. Z. (2022) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001408 · Cited by 5
Khader, T. A., Ahmad, W., Akhlaq, S., Panicker, N. G., Gull, B., Baby, J., Rizvi, T. A., & Mustafa, F. (2024) · Communications Biology · doi:10.1038/s42003-024-07139-9 · Cited by 4
Gomes, Y. C. P., Silva, M. T. T., Leite, A. C. C. B., Lima, M. A., Araújo, A., Filho, I. L. S., Vicente, A. C., & Espíndola, O. D. M. (2021) · Journal of General Virology · doi:10.1099/jgv.0.001649 · Cited by 5
Cell Transformation by RNA Viruses: An Overview
Fan, H. (2011) · Viruses · doi:10.3390/v3060858 · Cited by 4
“Kannian, P.; Green, P.L. Human T lymphotropic virus type 1 (HTLV-1): Molecular biology and oncogenesis.”
BackgroundApoptosis and Phagocytosis as Antiviral Mechanisms
Nainu, F., Ophinni, Y., Shiratsuchi, A., & Nakanishi, Y. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-40086-5_3 · Cited by 3
Viruses, cell transformation, and cancer
Bose, D., & Robertson, E. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818619-0.00092-7 · Cited by 3
Louten, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800947-5.00009-0 · Cited by 3
The Assembly of HTLV-1—How Does It Differ from HIV-1?
Herrmann, D., Meng, S., Yang, H., Mansky, L. M., & Saad, J. S. (2024) · Viruses · doi:10.3390/v16101528 · Cited by 5
“The unspliced, full-length gRNA serves as the viral genome and as a template for Gag, Pro, and Pol (Figure accessory genes are located downstream of the envelope (Env) gene and contains open ), Rex, splicing of the viral RNA [24,77].”
BackgroundBlood-Borne and Parasitic Infections: Role of Phytoformulations
Ishaq, Z., Sami, A., Batool, T. S., & Waheed, Y. (2026) · Advances in Science, Technology & Innovation/Advances in science, technology & innovation · doi:10.1007/978-3-032-15493-4_10 · Cited by 1
Targeting human oncogenic viruses with CRISPR/Cas: New therapeutic opportunities and challenges
Jigheh, M. P., Ravanlo, Z. Z., Shahrak, M. Z., Mohabbat, A., & Baghi, H. B. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119284 · Cited by 1
Franco, G. O., Stöcker, A., Netto, E. M., Pereira, H., & Brites, C. R. (2026) · Viruses · doi:10.3390/v18050580 · Cited by 1
Circular RNAs in virus-induced cancers: From mechanism to clinical implications
Ahmed, K., & Jha, S. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189619 · Cited by 1
The Role of Tumor Exosomes in Tumorigenicity
Zhang, H., & Skog, J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3697-3_8 · Cited by 1
Fungal metabolites—A potential source of antiviral compounds
Putatunda, C., Walia, A., Sharma, R., Thakur, A., & Mehta, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821006-2.00012-1 · Cited by 1
Report on Carcinogens Monograph on Human T-Cell Lymphotropic Virus Type 1
(NTP), N. T. P. (2016) · doi:10.22427/roc-mgraph-09 · Cited by 2
Metadata
- Authors
- Kannian, P., & Green, P. L.
- Affiliations
- The Ohio State University (US)
- Corresponding author
- Green, Patrick L.
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2010-09-24
- Volume
- 2
- Issue
- 9
- Pages
- 2037-2077
- ISSN
- 1999-4915 (ISSN-L)
- PMC
- PMC3185741
- OpenAlex
- W2040466820
- Cited by
- 139
- References
- 333
- Citations by year
- 2026: 9 · 2025: 1 · 2024: 9 · 2023: 15 · 2022: 9 · 2021: 9 · 2020: 3 · 2019: 7 · 2018: 9 · 2017: 9 · 2016: 9 · 2015: 11 · 2014: 9 · 2013: 10 · 2012: 12
- FWCI
- 4.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Viruses (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Keywords
- HTLV-1, T-cell transformation, carcinogenesis, adult T-cell leukemia/lymphoma, HTLV-1-associated myelopathy/tropical spastic paraparesis, HTLV-II, viral pathogenesis, viral proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.